Ching Chang Hwang

Title: Ching Chang Hwang: Innovator in Inflammatory Disease Assessment

Introduction

Ching Chang Hwang is a notable inventor based in South San Francisco, CA. She has made significant contributions to the field of medical diagnostics, particularly in the assessment of inflammatory diseases. Her innovative work has led to the development of methods that enhance the understanding and treatment of conditions such as rheumatoid arthritis.

Latest Patents

Hwang holds a patent for an "Adjusted multi-biomarker disease activity score for inflammatory disease assessment." This patent outlines methods for assessing responses to inflammatory disease therapy. The techniques involve performing immunoassays to generate scores based on quantitative data for the expression of biomarkers related to inflammatory diseases. These methods are crucial for accurately assessing disease activity and adjusting scores to account for various influencing factors.

Career Highlights

Ching Chang Hwang is associated with Laboratory Corporation of America Holdings, a leading company in the field of laboratory diagnostics. Her work at this organization has allowed her to focus on innovative solutions that improve patient care and treatment outcomes.

Collaborations

Hwang collaborates with esteemed colleagues, including David Chernoff and Alexander Gutin. These partnerships enhance her research and contribute to the advancement of diagnostic methodologies in inflammatory diseases.

Conclusion

Ching Chang Hwang's contributions to the field of inflammatory disease assessment exemplify the impact of innovation in medical diagnostics. Her work not only advances scientific understanding but also improves therapeutic strategies for patients suffering from inflammatory conditions.